BioLargo, Inc.
BLGO
Rank in Stocks
#25999
BioLargo, Inc. pioneers the invention, development, and commercialization of... BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
Share Price
$0.07
Last synced: 2026-11-11
Market Cap
$22.47M
Change (1 day)
0.00%
Change (1 year)
-58.82%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade BioLargo, Inc. (BLGO)
Category
Basic Materials
EPS for BioLargo, Inc. (BLGO)
EPS as of June 2026 TTM: $-0.05
According to BioLargo, Inc.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.04, a decrease compared to its 2024 EPS of $-0.01.
EPS history for BioLargo, Inc. from 2000 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | 13.00% |
| 2025 | $-0.04 | 374.07% |
| 2024 | $-0.01 | -34.15% |
| 2023 | $-0.01 | -26.79% |
| 2022 | $-0.02 | -43.62% |
| 2021 | $-0.03 | -44.19% |
| 2020 | $-0.05 | -44.95% |
| 2019 | $-0.10 | 15.75% |
| 2018 | $-0.08 | -9.01% |
| 2017 | $-0.09 | 3.25% |
| 2016 | $-0.09 | 48.42% |
| 2015 | $-0.06 | 30.37% |
| 2014 | $-0.05 | 32.85% |
| 2013 | $-0.03 | -58.54% |
| 2012 | $-0.08 | 17.89% |
| 2011 | $-0.07 | -45.38% |
| 2010 | $-0.13 | -64.86% |
| 2009 | $-0.37 | 117.65% |
| 2008 | $-0.17 | -5.56% |
| 2007 | $-0.18 | -62.50% |
| 2006 | $-0.48 | -12.73% |
| 2005 | $-0.55 | -16.67% |
| 2004 | $-0.66 | -89.44% |
| 2003 | $-6.25 | -50.44% |
| 2002 | $-12.61 | -67.73% |
| 2001 | $-39.08 | 148.60% |
| 2000 | $-15.72 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $0.19 | -523.45% |
TW
|
|
| $1.72 | -3,907.96% |
JP
|
|
| $7.42 | -16,506.64% |
DE
|
|
| $-1.82 | 3,925.88% |
SA
|
|
| $0.91 | -2,117.92% |
CN
|
Questions about BioLargo, Inc.'s earnings per share (EPS)
What is BioLargo, Inc.'s earnings per share (EPS)?
BioLargo, Inc.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Jun 2026.
What was BioLargo, Inc.'s earnings per share (EPS) in 2025?
In 2025, BioLargo, Inc.'s earnings per share (EPS) was $-0.04, compared with $-0.01 in 2024.
How has BioLargo, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, BioLargo, Inc.'s earnings per share (EPS) was highest in 2024 ($-0.01) and lowest in 2020 ($-0.05).
How does BioLargo, Inc.'s earnings per share (EPS) compare with similar companies?
BioLargo, Inc.'s earnings per share (EPS) ($-0.05) is higher than that of 1 of the 5 similar companies listed above. The highest among them is BASF Se, with $7.42.